urmjУральский медицинский журналUral Medical Journal2949-4389Ural State Medical University10.52420/umj.24.3.7AQOXUPurmj-1832Research ArticleОригинальные статьи | Original articlesOriginal articlesИзучение факторов, способствующих снижению рисков развития осложнений в послеоперационном периодеThe Study of Factors Related to the Risk of Complications in the Postoperative Period in Patients with Respiratory Tuberculosishttps://orcid.org/0009-0001-0690-927XКосенковС. А.KosenkovS. A.

Косенков Сергей Александрович — фтизиатр туберкулезного легочного отделения № 1, клиника № 1.

Москва

Sergey A. Kosenkov — Phthisiatrician of the Tuberculosis Pulmonary Department No. 1, Clinic No. 1, Moscow Research and Clinical Center for Tuberculosis Control.

Moscow

kosenkov_sergey@bk.ruhttps://orcid.org/0000-0001-8951-5219СиницынМ. В.SinitsynM. V.

Синицын Михаил Валерьевич — доктор медицинских наук, заместитель главного врача, НМИЦ ФПИ; доцент кафедры фтизиатрии, РМАНПО; профессор кафедры фтизиатрии, институт клинической медицины, РНИМУ им. Н.И. Пирогова.

Москва

Mikhail V. Sinitsyn — Doctor of Sciences (Medicine), Deputy Chief Physician, National Medical Research Center for Phthisiopulmonology and Infectious Diseases; Associate Professor of the Department of Phthisiology, Russian Medical Academy of Continuous Professional Education; Professor of the Department of Phthisiology, Institute of Clinical Medicine, Pirogov Russian National Research Medical University.

Moscow

msinitsyn@mail.ruhttps://orcid.org/0000-0002-9767-4022БелиловскийЕ. М.BelilovskyE. M.

Белиловский Евгений Михайлович — кандидат биологических наук, заведующий отделом эпидемиологического мониторинга туберкулеза.

Москва

Evgeny M. Belilovsky — Candidate of Sciences (Biology), Head of the Department of Epidemiological Monitoring of Tuberculosis, Moscow Research and Clinical Center for Tuberculosis Control.

Moscow

belilo5@mail.ruМосковский городской научно-практический центр борьбы с туберкулезомРоссияMoscow Research and Clinical Center for Tuberculosis ControlRussian FederationНациональный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний; Российская медицинская академия непрерывного профессионального образования; Российский национальный исследовательский медицинский университет имени Н.И. ПироговаРоссияNational Medical Research Center for Phthisiopulmonology and Infectious Diseases; Russian Medical Academy of Continuous Professional Education; Pirogov Russian National Research Medical UniversityRussian Federation2025060720252437–18Copyright © Косенков С.А., Синицын М.В., Белиловский Е.М., 20252025Косенков С.А., Синицын М.В., Белиловский Е.М.Kosenkov S.A., Sinitsyn M.V., Belilovsky E.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.umjusmu.ru/jour/article/view/1832Обоснование

Обоснование. Изучение факторов, связанных с развитием послеоперационных осложнений у больных туберкулезом органов дыхания, является первоочередной и актуальной задачей.

Цель — определение факторов, связанных с наличием послеоперационных осложнений у больных туберкулезом органов дыхания.

Материалы и методы

Материалы и методы. Проведено ретроспективное исследование данных 251 пациента с впервые выявленным туберкулезом органов дыхания и рецидивом, проходившего лечение в туберкулезном хирургическом отделении клиники № 1 Московского городского научно-практического центра борьбы с туберкулезом в 2017–2018 гг.

Результаты

Результаты. В послеоперационном периоде осложнения развились у 22/251 (8,76 %) больных. В ходе однофакторного анализа выявлено, что с появлением осложнений связаны инвалидность (p = 0,013), незаконченное образование (p = 0,017), потенциально неэффективный курс лечения (p = 0,014) и длительность заболевания от 6 мес. до 1 года (p = 0,044). Способствовать отсутствию осложнений может совпадение специальности, полученной при обучении, и дальнейшей работы (p = 0,005). Изучение совместного влияния факторов риска показало, что появление осложнений может быть связано с потенциально неэффективным курсом лечения (р = 0,006) и продолжительностью заболевания от 6 мес. до 1 года (р < 0,001).

Заключение

Заключение. Факторами, связанными с послеоперационными осложнениями у больных туберкулезом органов дыхания, являются инвалидность (p = 0,013), незаконченное образование (p = 0,017), потенциально неэффективный курс лечения (p = 0,014) и длительность заболевания от 6 мес. до 1 года (p = 0,044).

Introduction

Introduction. The study of the factors associated with the development of postoperative complications in patients with tuberculosis of the respiratory system is a priority and urgent task.

Objective — determination of factors related to the presence of postoperative complications in patients with tuberculosis of the respiratory system.

Materials and methods

Materials and methods. A retrospective study of the data of 251 patients with newly diagnosed respiratory tuberculosis and relapse who were treated in the tuberculosis surgical department of the clinic No. 1 of the Moscow Research and Clinical Center for Tuberculosis Control in 2017–2018 was conducted.

Results

Results. In the postoperative period, complications developed in 22/251 (8.76 %) patients. A single-factor analysis revealed that disability (p = 0.013), incomplete education (p = 0.017), potentially ineffective treatment (p = 0.014), and duration of the disease from 6 months to 1 year (p = 0.044) were associated with complications. The coincidence of the specialty obtained during training and further work can contribute to the absence of complications (p = 0.005). The study of the combined effect of risk factors showed that the occurrence of complications may be associated with a potentially ineffective course of treatment (p = 0.006) and the duration of the disease from 6 months to 1 year (p < 0.001).

Conclusion

Conclusion. The factors associated with postoperative complications in patients with respiratory tuberculosis are disability (p = 0.013), incomplete education (p = 0.017), potentially ineffective course of treatment (p = 0.014) and duration of the disease from 6 months to 1 year (p = 0.044).

туберкулез легкиххирургическое лечениекомплексное лечение туберкулезахимиотерапияэффективность хирургического леченияпослеоперационные осложненияpulmonary tuberculosissurgical treatmentcomplex treatment of tuberculosischemotherapyeffectiveness of surgical treatmentpostoperative complicationsReferencesBorisov SE, Dheda K, Enwerem M, Romero LR, D’Ambrosio L, Centis R, et al. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: A multicentre study. European Respiratory Journal. 2017;49(5):1700387. DOI: https://doi.org/10.1183/13993003.00387-2017.Borisov SE, Dheda K, Enwerem M, Romero LR, D’Ambrosio L, Centis R, et al. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: A multicentre study. European Respiratory Journal. 2017;49(5):1700387. DOI: https://doi.org/10.1183/13993003.00387-2017.Migliori GB, Tiberi S, Zumla A, Petersen E, Chakaya JM, Wejse C, et al. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. International Journal of Infectious Diseases. 2020;92(Suppl):S15–S25. DOI: https://doi.org/10.1016/j.ijid.2020.01.042.Migliori GB, Tiberi S, Zumla A, Petersen E, Chakaya JM, Wejse C, et al. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. International Journal of Infectious Diseases. 2020;92(Suppl):S15–S25. DOI: https://doi.org/10.1016/j.ijid.2020.01.042.Yablonskii PK, Vasilev IV, Sokolovich EG. The role of surgery in the diagnosis and the treatment of pulmonary tuberculosis. Vestnik of Saint Petersburg University. Medicine. 2016;11(3):64–70. (In Russ.). EDN: https://www.elibrary.ru/XGHWND.Yablonskii PK, Vasilev IV, Sokolovich EG. The role of surgery in the diagnosis and the treatment of pulmonary tuberculosis. Vestnik of Saint Petersburg University. Medicine. 2016;11(3):64–70. (In Russ.). EDN: https://www.elibrary.ru/XGHWND.Romanova MI, Gayda AI, Abramchenko AV, Mozhokina GN, Lovacheva OV. Effectiveness of surgical treatment of patients with destructive pulmonary tuberculosis (meta-analysis). Tuberculosis and Lung Diseases. 2024;102(2):52–61. (In Russ.). DOI: https://doi.org/10.58838/2075-1230-2024-102-2-52-61.Romanova MI, Gayda AI, Abramchenko AV, Mozhokina GN, Lovacheva OV. Effectiveness of surgical treatment of patients with destructive pulmonary tuberculosis (meta-analysis). Tuberculosis and Lung Diseases. 2024;102(2):52–61. (In Russ.). DOI: https://doi.org/10.58838/2075-1230-2024-102-2-52-61.Giller DB, Giller BD, Giller GV, Shcherbakova GV, Bizhanov AB, Enilenis II, et al. Treatment of pulmonary tuberculosis: Past and present. European Journal of Cardio-Thoracic Surgery. 2018;53(5):967–972. DOI: https://doi.org/10.1093/ejcts/ezx447.Giller DB, Giller BD, Giller GV, Shcherbakova GV, Bizhanov AB, Enilenis II, et al. Treatment of pulmonary tuberculosis: Past and present. European Journal of Cardio-Thoracic Surgery. 2018;53(5):967–972. DOI: https://doi.org/10.1093/ejcts/ezx447.Bogorodskaya EM, Belilovskiy EM, Sinitsyn MV, Borisov SE, Vorobyov AA, Matveeva MV. Remote results of surgical treatment of patients with tuberculosis. Medical Alliance. 2022;10(3):35–45. (In Russ.). DOI: https://doi.org/10.36422/23076348-2022-10-3-35-45.Bogorodskaya EM, Belilovskiy EM, Sinitsyn MV, Borisov SE, Vorobyov AA, Matveeva MV. Remote results of surgical treatment of patients with tuberculosis. Medical Alliance. 2022;10(3):35–45. (In Russ.). DOI: https://doi.org/10.36422/23076348-2022-10-3-35-45.Erimbetov KD, Bektursinov BU, Zetov AS. Efficiency of valve bronchial block within comprehensive treatment of pulmonary tuberculosis patients with extensive drug resistance. Tuberculosis and Lung Diseases. 2018;96(4):47–51. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-4-47-51.Erimbetov KD, Bektursinov BU, Zetov AS. Efficiency of valve bronchial block within comprehensive treatment of pulmonary tuberculosis patients with extensive drug resistance. Tuberculosis and Lung Diseases. 2018;96(4):47–51. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-4-47-51.Askalonova OY, Tseymakh EA, Levin AV, Zimonin PE. Endobronchial valve in complex treatment of patients with drug resistant fibrous cavernous pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2020; 98(1):35–40. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2020-98-1-35-40.Askalonova OY, Tseymakh EA, Levin AV, Zimonin PE. Endobronchial valve in complex treatment of patients with drug resistant fibrous cavernous pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2020; 98(1):35–40. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2020-98-1-35-40.Golubchikov PN, Schegertsov DY, Melnikovа TI, Krаsnov DV, Skvortsov DA, Grischenko NG. A clinical case of successful combined treatment of a patient with fibrous cavernous pulmonary tuberculosis and extensive drug resistance. Tuberculosis and Lung Diseases. 2020;98(6):52–59. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2020-98-6-52-59.Golubchikov PN, Schegertsov DY, Melnikovа TI, Krаsnov DV, Skvortsov DA, Grischenko NG. A clinical case of successful combined treatment of a patient with fibrous cavernous pulmonary tuberculosis and extensive drug resistance. Tuberculosis and Lung Diseases. 2020;98(6):52–59. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2020-98-6-52-59.Komissarova OG, Аbdullaev RY, Aleshina SV. Frequency and characteristics of adverse events caused by anti-tuberculosis drugs in pulmonary tuberculosis patients with diabetes myelitis. Tuberculosis and Lung Diseases. 2020;98(2):10–14. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2020-98-2-10-14.Komissarova OG, Аbdullaev RY, Aleshina SV. Frequency and characteristics of adverse events caused by anti-tuberculosis drugs in pulmonary tuberculosis patients with diabetes myelitis. Tuberculosis and Lung Diseases. 2020;98(2):10–14. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2020-98-2-10-14.Schegertsov DY, Filinyuk OV, Buynova LN, Zemlyanaya NA, Kabanets NN, Aliluev AS. Adverse events during treatment of patients suffering from multiple drug resistant tuberculosis. Tuberculosis and Lung Diseases. 2018;96(3):35–43. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-3-35-43.Schegertsov DY, Filinyuk OV, Buynova LN, Zemlyanaya NA, Kabanets NN, Aliluev AS. Adverse events during treatment of patients suffering from multiple drug resistant tuberculosis. Tuberculosis and Lung Diseases. 2018;96(3):35–43. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-3-35-43.Pavlova MV, Starshinova AA, Sapozhnikova NV, Chernokhaeva IV, Archakova LI, Yablonskiy PK. Efficiency of integral therapy and potential side effects when treating respiratory tuberculosis with multiple drug resistance. Tuberculosis and Lung Diseases. 2015;(12):61–67. (In Russ.). EDN: https://elibrary.ru/VMHZWR.Pavlova MV, Starshinova AA, Sapozhnikova NV, Chernokhaeva IV, Archakova LI, Yablonskiy PK. Efficiency of integral therapy and potential side effects when treating respiratory tuberculosis with multiple drug resistance. Tuberculosis and Lung Diseases. 2015;(12):61–67. (In Russ.). EDN: https://elibrary.ru/VMHZWR.Dara M, Sotgiu G, Zaleskis R, Migliori GB. Untreatable tuberculosis: Is surgery the answer? European Respiratory Journal. 2015;45(3):577–582. DOI: https://doi.org/10.1183/09031936.00229514.Dara M, Sotgiu G, Zaleskis R, Migliori GB. Untreatable tuberculosis: Is surgery the answer? European Respiratory Journal. 2015;45(3):577–582. DOI: https://doi.org/10.1183/09031936.00229514.Kilani T, Boudaya MS, Zribi H, Ouerghi S, Marghli A, Mestiri T, et al. Surgery for thoracic tuberculosis. Revue de Pneumologie Clinique. 2015;71(2–3):140–158. DOI: https://doi.org/10.1016/j.pneumo.2014.03.005.Kilani T, Boudaya MS, Zribi H, Ouerghi S, Marghli A, Mestiri T, et al. Surgery for thoracic tuberculosis. Revue de Pneumologie Clinique. 2015;71(2–3):140–158. DOI: https://doi.org/10.1016/j.pneumo.2014.03.005.Madansein R, Parida S, Padayatchi N, Singh N, Master I, Naidu K, et al. Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis. International Journal of Infectious Diseases. 2015;32:61–67. DOI: https://doi.org/10.1016/j.ijid.2015.01.019.Madansein R, Parida S, Padayatchi N, Singh N, Master I, Naidu K, et al. Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis. International Journal of Infectious Diseases. 2015;32:61–67. DOI: https://doi.org/10.1016/j.ijid.2015.01.019.Marrone MT, Venkataramanan V, Goodman M, Hill AC, Jereb JA, Mase SR. Surgical interventions for drug-resistant tuberculosis: A systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease. 2013;17(1):6–16. DOI: https://doi.org/10.5588/ijtld.12.0198.Marrone MT, Venkataramanan V, Goodman M, Hill AC, Jereb JA, Mase SR. Surgical interventions for drug-resistant tuberculosis: A systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease. 2013;17(1):6–16. DOI: https://doi.org/10.5588/ijtld.12.0198.Tiberi S, Torrico MM, Rahman A, Krutikov M, Visca D, Silva DR, et al. Managing severe tuberculosis and its sequelae: From intensive care to surgery and rehabilitation. Jornal Brasileiro de Pneumologia. 2019;45(2): e20180324. DOI: https://doi.org/10.1590/1806-3713/e20180324.Tiberi S, Torrico MM, Rahman A, Krutikov M, Visca D, Silva DR, et al. Managing severe tuberculosis and its sequelae: From intensive care to surgery and rehabilitation. Jornal Brasileiro de Pneumologia. 2019;45(2): e20180324. DOI: https://doi.org/10.1590/1806-3713/e20180324.Subotic D, Yablonskiy P, Sulis G, Cordos I, Petrov D, Centis R, et al. Surgery and pleuro-pulmonary tuberculosis: A scientific literature review. Journal of Thoracic Disease. 2016;8(7):E474–E485. DOI: https://doi.org/10.21037/jtd.2016.05.59.Subotic D, Yablonskiy P, Sulis G, Cordos I, Petrov D, Centis R, et al. Surgery and pleuro-pulmonary tuberculosis: A scientific literature review. Journal of Thoracic Disease. 2016;8(7):E474–E485. DOI: https://doi.org/10.21037/jtd.2016.05.59.Borovikov OV, Surdul AY, Pavlova EV, Tarutin VY. Outcomes of surgical treatment in patients with disseminated fibrous cavernous pulmonary tuberculosis using bone-muscle plastics and endobronchial valve block. Tuberculosis and Lung Diseases. 2018;96(12):62–63. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-12-62-63.Borovikov OV, Surdul AY, Pavlova EV, Tarutin VY. Outcomes of surgical treatment in patients with disseminated fibrous cavernous pulmonary tuberculosis using bone-muscle plastics and endobronchial valve block. Tuberculosis and Lung Diseases. 2018;96(12):62–63. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-12-62-63.Belov SA. Application of transplants in collapse surgery in patients with lung tuberculosis. Pacific Medical Journal. 2020;(1):23–27. (In Russ.). DOI: https://doi.org/10.34215/1609-1175-2020-1-23-27.Belov SA. Application of transplants in collapse surgery in patients with lung tuberculosis. Pacific Medical Journal. 2020;(1):23–27. (In Russ.). DOI: https://doi.org/10.34215/1609-1175-2020-1-23-27.Yablonskiy PK, Vasilev IV, Kirjuhina LD, Avetisjan AО, Volodich OS, Gavrilov PV, et al. Immediate results of pneumonectomies in patients with unilateral localization of destructive pulmonary tuberculosis. Results of a prospective non-randomized study. Medical Alliance. 2017;(4):103–111. (In Russ.). EDN: https://elibrary.ru/YQXUUM.Yablonskiy PK, Vasilev IV, Kirjuhina LD, Avetisjan AО, Volodich OS, Gavrilov PV, et al. Immediate results of pneumonectomies in patients with unilateral localization of destructive pulmonary tuberculosis. Results of a prospective non-randomized study. Medical Alliance. 2017;(4):103–111. (In Russ.). EDN: https://elibrary.ru/YQXUUM.Reykhrud MV, Krasnov DV, Avdienko KA, Grischenko NG, Skvortsov DA, Kononenko VG. Postpones out-comes of resection and collapse surgical interventions for pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2018;96(12):34–40. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-12-34-40.Reykhrud MV, Krasnov DV, Avdienko KA, Grischenko NG, Skvortsov DA, Kononenko VG. Postpones out-comes of resection and collapse surgical interventions for pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2018;96(12):34–40. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-12-34-40.Batyrshina YR, Krasnov VA, Petrenko TI. Treatment outcomes of multiple and extensive drug resistant tuberculosis and efficiency of surgical resections in patients with high risk of unfavorable outcomes. Tuberculosis and Lung Diseases. 2016;94(5):28–34. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2016-94-5-28-34.Batyrshina YR, Krasnov VA, Petrenko TI. Treatment outcomes of multiple and extensive drug resistant tuberculosis and efficiency of surgical resections in patients with high risk of unfavorable outcomes. Tuberculosis and Lung Diseases. 2016;94(5):28–34. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2016-94-5-28-34.Rogozhkin PV, Borodulina EA. The postponed treatment outcomes in pulmonary tuberculosis patients after radical pulmonary resection. Tuberculosis and Lung Diseases. 2018;96(3):24–28. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-3-24-28.Rogozhkin PV, Borodulina EA. The postponed treatment outcomes in pulmonary tuberculosis patients after radical pulmonary resection. Tuberculosis and Lung Diseases. 2018;96(3):24–28. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-3-24-28.Giller DB, Ilyukhin AN, Mayusupov SE, Saenko SS, Shcherbakova GV, Kesaev OS. Risk factors for postoperative complications and tuberculosis relapses: A retrospective study. Tuberculosis and Socially Significant Diseases. 2024;12(3):44–50. (In Russ.). DOI: https://doi.org/10.54921/2413-0346-2024-12-3-44-50.Giller DB, Ilyukhin AN, Mayusupov SE, Saenko SS, Shcherbakova GV, Kesaev OS. Risk factors for postoperative complications and tuberculosis relapses: A retrospective study. Tuberculosis and Socially Significant Diseases. 2024;12(3):44–50. (In Russ.). DOI: https://doi.org/10.54921/2413-0346-2024-12-3-44-50.

The authors declare that there are no conflicts of interest present.